331 related articles for article (PubMed ID: 25735856)
1. Electrocardiographic Left Ventricular Hypertrophy as a Predictor for Nonsignificant Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction.
Misumida N; Kobayashi A; Saeed M; Fox JT; Kanei Y
Angiology; 2016 Jan; 67(1):27-33. PubMed ID: 25735856
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction.
Barrabés JA; Figueras J; Cortadellas J; Lidón RM; Ibars S
Am J Cardiol; 2009 Feb; 103(4):455-60. PubMed ID: 19195501
[TBL] [Abstract][Full Text] [Related]
3. Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non-ST-segment elevation myocardial infarction.
Patel JH; Gupta R; Roe MT; Peng SA; Wiviott SD; Saucedo JF
Am J Cardiol; 2014 Jan; 113(2):256-61. PubMed ID: 24290492
[TBL] [Abstract][Full Text] [Related]
4. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
[TBL] [Abstract][Full Text] [Related]
5. The role of left ventricular hypertrophy and diabetes in the presence of transient ischemic dilation of the left ventricle on myocardial perfusion SPECT images.
Emmett L; Magee M; Freedman SB; Van der Wall H; Bush V; Trieu J; Van Gaal W; Allman KC; Kritharides L
J Nucl Med; 2005 Oct; 46(10):1596-601. PubMed ID: 16204708
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative.
Patel MR; Chen AY; Peterson ED; Newby LK; Pollack CV; Brindis RG; Gibson CM; Kleiman NS; Saucedo JF; Bhatt DL; Gibler WB; Ohman EM; Harrington RA; Roe MT
Am Heart J; 2006 Oct; 152(4):641-7. PubMed ID: 16996828
[TBL] [Abstract][Full Text] [Related]
7. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
8. Predictors of ventricular fibrillation at reperfusion in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
Demidova MM; Carlson J; Erlinge D; Platonov PG
Am J Cardiol; 2015 Feb; 115(4):417-22. PubMed ID: 25549882
[TBL] [Abstract][Full Text] [Related]
9. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
Agarwal R; Light RP
Clin J Am Soc Nephrol; 2011 Mar; 6(3):528-36. PubMed ID: 21088286
[TBL] [Abstract][Full Text] [Related]
10. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Planer D; Mehran R; Ohman EM; White HD; Newman JD; Xu K; Stone GW
Circ Cardiovasc Interv; 2014 Jun; 7(3):285-93. PubMed ID: 24847016
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular hypertrophy contributes to Myocardial Ischemia in Non-obstructive Coronary Artery Disease (the MicroCAD study).
Eskerud I; Gerdts E; Larsen TH; Lønnebakken MT
Int J Cardiol; 2019 Jul; 286():1-6. PubMed ID: 30952529
[TBL] [Abstract][Full Text] [Related]
13. Electrocardiographic left ventricular hypertrophy is not associated with increased in-hospital adverse events in patients with first Non-ST segment elevation myocardial infarction: A single center study.
Bakhtiari F; Davarmoin G; Ghaffari S; Aslanabadi N; Separham A
Caspian J Intern Med; 2019; 10(3):289-294. PubMed ID: 31558990
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarction.
Georgescu A; Fu Y; Yau C; Hassan Q; Luchansky J; Armstrong PW; Wagner G; Van de Werf F; Goodman SG;
Am J Cardiol; 2005 Oct; 96(8):1050-2. PubMed ID: 16214436
[TBL] [Abstract][Full Text] [Related]
15. Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia--its influence on diagnosis, triage, and short-term prognosis: a multicenter study.
Larsen GC; Griffith JL; Beshansky JR; D'Agostino RB; Selker HP
J Gen Intern Med; 1994 Dec; 9(12):666-73. PubMed ID: 7876948
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-lymphocyte ratio as an independent predictor of left main and/or three-vessel disease in patients with non-ST-segment elevation myocardial infarction.
Misumida N; Kobayashi A; Saeed M; Fox JT; Kanei Y
Cardiovasc Revasc Med; 2015 Sep; 16(6):331-5. PubMed ID: 26051172
[TBL] [Abstract][Full Text] [Related]
17. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
18. Global Coronary Artery Plaque Area is Associated with Myocardial Hypoperfusion in Women with Non-ST Elevation Myocardial Infarction.
Eskerud I; Gerdts E; Nordrehaug JE; Lønnebakken MT
J Womens Health (Larchmt); 2015 May; 24(5):367-73. PubMed ID: 25692527
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial).
Larsen AI; Nilsen DW; Yu J; Mehran R; Nikolsky E; Lansky AJ; Caixeta A; Parise H; Fahy M; Cristea E; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Stone GW
Am J Cardiol; 2013 Mar; 111(5):643-8. PubMed ID: 23261001
[TBL] [Abstract][Full Text] [Related]
20. Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.
Westerhout CM; Lauer MS; James S; Fu Y; Wallentin L; Armstrong PW;
Eur Heart J; 2007 Sep; 28(17):2064-9. PubMed ID: 17600040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
